Patent details

EP1381356 Title: use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1381356
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP02763962.4
WO Publication Number:
EPO Publication Language:
English
SPC Number:
300644
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
04/04/2002
Grant date:
28/05/2008
EP Publication Date:
28/05/2008
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
28/05/2008
EP B1 Publication Date:
28/05/2008
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
03/04/2022
Lapsed By Expiration Date:
04/04/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
07/05/2019
 
 

 

Name:
Sanofi-aventis Deutschland GmbH
Address:
Brüningstrasse 50, 65929, FRANKFURT AM MAIN, France (FR)

Historical Applicant/holder

From:
26/08/2016
To:
07/05/2019

 

Name:
Aventisub LLC
Address:
3711 Kennett Pike, Suite 200, 19807, GREENVILLE, Delaware, United States of America (US)

From:
28/05/2008
To:
26/08/2016

 

Name:
Aventis Pharmaceuticals Inc.
Address:
55 Corporate Drive, 08807, Bridgewater, New Jersey, United States of America (US)

Inventor

Name:
Joseph WETTSTEIN
Address:
NJ 08833, Lebanon, United States of America (US)

Priority

1

Priority Patent Number:
0123571
Priority Date:
02/10/2001
Priority Country:
United Kingdom (GB)

2

Priority Patent Number:
281685 P
Priority Date:
05/04/2001
Priority Country:
United States of America (US)

Classification

Main IPC Class:
A61K 31/165;
IPC or IDT classification:
A61P 25/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
14/22
Publication date:
06/04/2022
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
25/19
Publication date:
19/06/2019
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
41/16
Publication date:
12/10/2016
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
EP3
Journal edition number:
2008/11
Publication date:
03/11/2008
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

5

Bulletin Heading:
EP2
Journal edition number:
2008/08
Publication date:
01/08/2008
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
200823
Publication date:
04/06/2008
Description:
Grant (B1)

2

Issue number:
200822
Publication date:
28/05/2008
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201900867A
Date Registered:
07/05/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Sanofi-aventis Deutschland GmbH
Address:
Brüningstrasse 50, 65929, FRANKFURT AM MAIN, France (FR)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC201602162A
Date Registered:
26/08/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Aventisub LLC
Address:
3711 Kennett Pike, Suite 200, 19807, GREENVILLE, Delaware, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
12/03/2021
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
06/10/2016 Outgoing Correspondence Letter registration deed 1 PDF /2/6/9/3/6/0502763962/docs/ep02763962.4_2_88397l118.pdf
26/08/2016 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /2/6/9/3/6/0502763962/docs/ep02763962.4_3_incomingcorrespondencepaper20160929034620126.pdf
26/08/2016 Request for Change First filed deed 3 PDF /2/6/9/3/6/0502763962/docs/ep02763962.4_4_rfc20160929034620212.pdf
22/08/2008 Incoming Correspondence Paper Other 1 PDF /2/6/9/3/6/0502763962/docs/ep02763962.4_0_incomingcorrespondencepaper20080822.pdf
22/08/2008 Claims Translated claims 1 PDF /2/6/9/3/6/0502763962/docs/ep02763962.4_1_claims20080822.pdf